Discover 2,272 paid clinical trials in Berkeley, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,272
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
for
Hodgkin Lymphoma in Remission, Leukemia in Remission,
Location: Oakland CA, Palo Alto CA, Duarte CA, Las Vegas NV,
Sponsor: Children's Oncology Group
Sex: All
Age: 0+
Code: NCT01790152
Recruiting
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
for
Ovarian Carcinoma
Location: Oakland CA, Richmond CA, San Francisco CA,
Sponsor: NRG Oncology
Sex: Female
Age: 35 - 50
Code: NCT04251052
Recruiting
A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning
for
Sarcoma, Ewing, Chondrosarcoma, Osteosarcoma,
Location: Oakland CA, Royal Oak MI, Columbus OH
Sponsor: Ricoh USA, Inc.
Sex: All
Age: 13+
Code: NCT06387485
Recruiting
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia
Location: Oakland CA, San Francisco CA, Walnut Creek CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06317649
Phase2, Recruiting
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
for
Acute Myeloid Leukemia,
Location: Oakland CA, San Francisco CA, Walnut Creek CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05564390
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
for
Childhood Medulloblastoma
Location: Oakland CA, San Francisco CA, Sacramento CA, Madera CA,
Sponsor: Children's Oncology Group
Sex: All
Age: 4 - 21
Code: NCT05382338
Phase3, Recruiting
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Oakland CA, San Francisco CA, Walnut Creek CA,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06616584
Phase2, Phase3, Recruiting
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
for
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8,
Location: Oakland CA, Richmond CA, San Francisco CA,
Sponsor: NRG Oncology
Sex: Male
Age: 18+
Code: NCT05946213
Phase3, Recruiting
Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer
for
Metastatic Nasopharyngeal Carcinoma,
Location: Oakland CA, San Francisco CA, Walnut Creek CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06029270
Phase2, Recruiting
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Oakland CA, San Francisco CA, Walnut Creek CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05987241
Phase2, Phase3, Recruiting
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
for
Central Nervous System Nongerminomatous Germ Cell Tumor,
Location: Oakland CA, San Francisco CA, Palo Alto CA, Madera CA,
Sponsor: Children's Oncology Group
Sex: All
Age: 3 - 29
Code: NCT04684368
Phase2, Recruiting
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
for
Grade 2 Meningioma, Intracranial Meningioma
Location: Oakland CA, San Francisco CA, South San Francisco CA,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT03180268
Phase3, Recruiting
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab